Ananda Pharma appoints former GW Pharmaceuticals executive Chris Tovey as adviser

Ananda Pharma Plc (AQSE:ANA)has appointed Chris Tovey, former chief operating officer of GW Pharmaceuticals and Jazz Pharmaceuticals, as a strategic adviser to support the company’s efforts to develop cannabinoid-based medicines. Tovey played a central role at GW, the first company to secure regulatory approval for a cannabidiol (CBD) medicine in the United States, United Kingdom […]